A detailed history of Foyston, Gordon, & Payne Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Foyston, Gordon, & Payne Inc holds 40,465 shares of JNJ stock, worth $5.89 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares
40,465
Previous 69,068 41.41%
Holding current value
$5.89 Million
Previous $10.1 Million 35.04%
% of portfolio
1.67%
Previous 2.55%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $4.16 Million - $4.79 Million
-28,603 Reduced 41.41%
40,465 $6.56 Million
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $3.3 Million - $3.61 Million
-22,873 Reduced 24.88%
69,068 $10.1 Million
Q1 2024

May 07, 2024

SELL
$155.22 - $162.74 $277,843 - $291,304
-1,790 Reduced 1.91%
91,941 $14.5 Million
Q4 2023

Feb 07, 2024

SELL
$145.6 - $158.88 $16,598 - $18,112
-114 Reduced 0.12%
93,731 $14.7 Million
Q3 2023

Oct 26, 2023

SELL
$155.75 - $174.48 $2.67 Million - $2.99 Million
-17,129 Reduced 15.44%
93,845 $14.6 Million
Q2 2023

Aug 01, 2023

BUY
$154.35 - $166.11 $66,833 - $71,925
433 Added 0.39%
110,974 $18.4 Million
Q1 2023

May 03, 2023

BUY
$151.05 - $180.26 $351,040 - $418,924
2,324 Added 2.15%
110,541 $17.1 Million
Q4 2022

Feb 09, 2023

SELL
$160.2 - $179.79 $2.05 Million - $2.3 Million
-12,811 Reduced 10.59%
108,217 $19.1 Million
Q3 2022

Nov 04, 2022

BUY
$161.33 - $179.52 $582,562 - $648,246
3,611 Added 3.08%
121,028 $19.8 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $2.85 Million - $3.15 Million
-16,928 Reduced 12.6%
117,417 $23.1 Million
Q1 2022

Apr 27, 2022

BUY
$158.14 - $179.59 $578,159 - $656,581
3,656 Added 2.8%
134,345 $23.8 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $383,743 - $425,777
-2,461 Reduced 1.85%
130,689 $22.4 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $260,338 - $289,305
-1,612 Reduced 1.2%
133,150 $21.5 Million
Q2 2021

Aug 06, 2021

SELL
$159.48 - $171.07 $1.48 Million - $1.58 Million
-9,253 Reduced 6.43%
134,762 $22.2 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $1.16 Million - $1.3 Million
-7,604 Reduced 5.02%
144,015 $23.7 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $2.02 Million - $2.31 Million
-14,704 Reduced 8.84%
151,619 $23.9 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $6.35 Million - $6.96 Million
-45,214 Reduced 21.37%
166,323 $24.8 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $2.22 Million - $2.68 Million
-17,227 Reduced 7.53%
211,537 $29.7 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $1.28 Million - $1.77 Million
-11,489 Reduced 4.78%
228,764 $30 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $81,600 - $93,721
-640 Reduced 0.27%
240,253 $35 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $3.01 Million - $3.37 Million
-23,711 Reduced 8.96%
240,893 $31.2 Million
Q2 2019

Aug 15, 2019

BUY
$131.15 - $144.24 $259,283 - $285,162
1,977 Added 0.75%
264,604 $36.9 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $136,909 - $152,231
-1,089 Reduced 0.41%
262,627 $36.7 Million
Q4 2018

Feb 08, 2019

BUY
$122.84 - $147.84 $1.04 Million - $1.25 Million
8,466 Added 3.32%
263,716 $34 Million
Q3 2018

Nov 02, 2018

SELL
$121.58 - $142.88 $512,581 - $602,382
-4,216 Reduced 1.62%
255,250 $35.3 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $1.52 Million - $1.68 Million
12,750 Added 5.17%
259,466 $31.5 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $2.68 Million - $3.18 Million
21,440 Added 9.52%
246,716 $31.6 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $24.3 Million - $26.6 Million
-185,499 Reduced 45.16%
225,276 $31.5 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $26.8 Million - $28 Million
207,088 Added 101.67%
410,775 $53.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
203,687
203,687 $26.9 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Foyston, Gordon, & Payne Inc Portfolio

Follow Foyston, Gordon, & Payne Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.